Back to: products

Asia Pacific Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook

PrintEmail
Jun 2021 - 102 Pages - From $2,600
(Excel Data Sheet: $1,500)
Description

The report cover may be different from the image shown.

Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

Asia Pacific biosurgery market will grow by 8.9% annually with a total addressable market cap of $33.2 billion over 2021-2027 owing to the growth in joint reconstruction and spinal fusion, the increasing number of surgeries especially minimally invasive surgeries due to lifestyle disorders and the rise in the overweight & aging population.
Highlighted with 31 tables and 49 figures, this 102-page report “Asia Pacific Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific biosurgery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific biosurgery market in every aspect of the classification from perspectives of Product, Source Type, Application, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Hemostatic Agents
• Bone-graft Substitutes
o Synthetic Graft Extender
o Demineralized Bone Matrix
o Bone Morphogenetic Proteins
o Cell-Based Matrices
• Surgical Sealants and Adhesives
o Natural Surgical Sealing Agents
o Synthetic Surgical Sealing Agents
• Soft-tissue Attachments
o Natural & Biological Mesh/Patch
o Synthetic Mesh/Patch
• Adhesion Barriers
o Natural Adhesion Barriers
o Synthetic Adhesion Barriers
• Staple Line Reinforcement

Based on Source Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Natural/Biological Products
• Synthetic Products

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Gynecological Surgery
• Other Applications

Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of key national markets by Product, Source Type, and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
B. Braun Melsungen AG
Baxter International, Inc.
Becton, Dickinson and Company (C.R. Bard)
Betatech Medical
CryoLife Inc.
CSL Limited
Hemostasis LLC
Integra Lifesciences Holdings Corporation
Johnson & Johnson
Medtronic PLC
Pfizer, Inc.
Sanofi S.A.
Stryker Corporation
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15
2 Market Overview and Dynamics 17
2.1 Market Size and Forecast 17
2.1.1 Impact of COVID-19 on World Economy 18
2.1.2 Impact of COVID-19 on the Market 20
2.2 Major Growth Drivers 22
2.3 Market Restraints and Challenges 26
2.4 Emerging Opportunities and Market Trends 29
2.5 Porter’s Fiver Forces Analysis 33
3 Segmentation of Asia Pacific Market by Product 37
3.1 Market Overview by Product 37
3.2 Hemostatic Agents 39
3.3 Bone-graft Substitutes 40
3.2.1 Synthetic Graft Extender 41
3.2.2 Demineralized Bone Matrix 42
3.2.3 Bone Morphogenetic Proteins 43
3.2.4 Cell-Based Matrices 44
3.4 Surgical Sealants and Adhesives 45
3.4.1 Natural Surgical Sealing Agents 46
3.4.2 Synthetic Surgical Sealing Agents 47
3.5 Soft-tissue Attachments 48
3.5.1 Natural & Biological Mesh/Patch 49
3.5.2 Synthetic Mesh/Patch 50
3.6 Adhesion Barriers 51
3.6.1 Natural Adhesion Barriers 52
3.6.2 Synthetic Adhesion Barriers 53
3.7 Staple Line Reinforcement 54
4 Segmentation of Asia Pacific Market by Source Type 55
4.1 Market Overview by Source Type 55
4.2 Natural/Biological Products 57
4.3 Synthetic Products 58
5 Segmentation of Asia Pacific Market by Application 60
5.1 Market Overview by Application 60
5.2 Orthopedic Surgery 62
5.3 General Surgery 63
5.4 Neurological Surgery 64
5.5 Cardiovascular Surgery 65
5.6 Gynecological Surgery 66
5.7 Other Applications 67
6 Asia-Pacific Market 2020-2027 by Country 68
6.1 Overview of Asia-Pacific Market 68
6.2 China 71
6.3 Japan 73
6.4 India 76
6.5 Australia 78
6.6 South Korea 80
6.7 Rest of APAC Region 82
7 Competitive Landscape 84
7.1 Overview of Key Vendors 84
7.2 New Product Launch, Partnership, Investment, and M&A 87
7.3 Company Profiles 88
B. Braun Melsungen AG 88
Baxter International, Inc. 90
Becton, Dickinson and Company (C.R. Bard) 91
Betatech Medical 92
CryoLife Inc. 93
CSL Limited 94
Hemostasis LLC 95
Integra Lifesciences Holdings Corporation 96
Johnson & Johnson 97
Medtronic PLC 98
Pfizer, Inc. 99
Sanofi S.A. 100
Stryker Corporation 101
RELATED REPORTS 102

List of Tables:

Table 1. Snapshot of Asia Pacific Biosurgery Market in Balanced Perspective, 2020-2027 16
Table 2. Growth Rate of World GDP, 2020-2022 19
Table 3. Main Product Trends and Market Opportunities in Asia Pacific Biosurgery Market 29
Table 4. Asia Pacific Biosurgery Market by Product, 2017-2027, $ mn 37
Table 5. Asia Pacific Biosurgery Market: Bone-Graft Substitutes by Type, 2017-2027, $ mn 40
Table 6. Asia Pacific Biosurgery Market: Surgical Sealants and Adhesives by Type, 2017-2027, $ mn 45
Table 7. Asia Pacific Biosurgery Market: Soft-tissue Attachments by Type, 2017-2027, $ mn 48
Table 8. Asia Pacific Biosurgery Market: Adhesion Barriers by Type, 2017-2027, $ mn 51
Table 9. Asia Pacific Biosurgery Market by Source Type, 2017-2027, $ mn 55
Table 10. Asia Pacific Biosurgery Market by Application, 2017-2027, $ mn 60
Table 11. APAC Biosurgery Market by Country, 2017-2027, $ mn 69
Table 12. China Biosurgery Market by Product, 2017-2027, $ mn 72
Table 13. China Biosurgery Market by Source Type, 2017-2027, $ mn 72
Table 14. China Biosurgery Market by Application, 2017-2027, $ mn 72
Table 15. Japan Biosurgery Market by Product, 2017-2027, $ mn 75
Table 16. Japan Biosurgery Market by Source Type, 2017-2027, $ mn 75
Table 17. Japan Biosurgery Market by Application, 2017-2027, $ mn 75
Table 18. India Biosurgery Market by Product, 2017-2027, $ mn 77
Table 19. India Biosurgery Market by Source Type, 2017-2027, $ mn 77
Table 20. India Biosurgery Market by Application, 2017-2027, $ mn 77
Table 21. Australia Biosurgery Market by Product, 2017-2027, $ mn 79
Table 22. Australia Biosurgery Market by Source Type, 2017-2027, $ mn 79
Table 23. Australia Biosurgery Market by Application, 2017-2027, $ mn 79
Table 24. South Korea Biosurgery Market by Product, 2017-2027, $ mn 81
Table 25. South Korea Biosurgery Market by Source Type, 2017-2027, $ mn 81
Table 26. South Korea Biosurgery Market by Application, 2017-2027, $ mn 81
Table 27. Biosurgery Market in Rest of APAC by Country/Region, 2017-2027, $ mn 83
Table 28. B. Braun Melsungen AG: Company Snapshot 88
Table 29. B. Braun Melsungen AG: Business Segmentation 88
Table 30. B. Braun Melsungen AG: Product Portfolio 89
Table 31. B. Braun Melsungen AG: Revenue, 2017-2019, $ mn 89

 

 

List of Figures:

Figure 1. Research Method Flow Chart 10
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 13
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 15
Figure 4. Asia Pacific Biosurgery Market, 2017-2027, $ mn 17
Figure 5. Impact of COVID-19 on Business 20
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Biosurgery Market 22
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 25
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Biosurgery Market 26
Figure 9. Investment Opportunity Analysis 30
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Biosurgery Market 33
Figure 11. Breakdown of Asia Pacific Biosurgery Market by Product, 2020-2027, % of Revenue 37
Figure 12. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Product, Value ($ mn) and Share (%) 38
Figure 13. Asia Pacific Biosurgery Market: Hemostatic Agents, 2017-2027, $ mn 39
Figure 14. Asia Pacific Biosurgery Market: Bone-graft Substitutes, 2017-2027, $ mn 40
Figure 15. Asia Pacific Biosurgery Market: Synthetic Graft Extender, 2017-2027, $ mn 41
Figure 16. Asia Pacific Biosurgery Market: Demineralized Bone Matrix, 2017-2027, $ mn 42
Figure 17. Asia Pacific Biosurgery Market: Bone Morphogenetic Proteins, 2017-2027, $ mn 43
Figure 18. Asia Pacific Biosurgery Market: Cell-Based Matrices, 2017-2027, $ mn 44
Figure 19. Asia Pacific Biosurgery Market: Surgical Sealants and Adhesives, 2017-2027, $ mn 45
Figure 20. Asia Pacific Biosurgery Market: Natural Surgical Sealing Agents, 2017-2027, $ mn 46
Figure 21. Asia Pacific Biosurgery Market: Synthetic Surgical Sealing Agents, 2017-2027, $ mn 47
Figure 22. Asia Pacific Biosurgery Market: Soft-tissue Attachments, 2017-2027, $ mn 48
Figure 23. Asia Pacific Biosurgery Market: Natural & Biological Mesh/Patch, 2017-2027, $ mn 49
Figure 24. Asia Pacific Biosurgery Market: Synthetic Mesh/Patch, 2017-2027, $ mn 50
Figure 25. Asia Pacific Biosurgery Market: Adhesion Barriers, 2017-2027, $ mn 51
Figure 26. Asia Pacific Biosurgery Market: Natural Adhesion Barriers, 2017-2027, $ mn 52
Figure 27. Asia Pacific Biosurgery Market: Synthetic Adhesion Barriers, 2017-2027, $ mn 53
Figure 28. Asia Pacific Biosurgery Market: Staple Line Reinforcement, 2017-2027, $ mn 54
Figure 29. Breakdown of Asia Pacific Biosurgery Market by Source Type, 2020-2027, % of Revenue 55
Figure 30. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Source Type, Value ($ mn) and Share (%) 56
Figure 31. Asia Pacific Biosurgery Market: Natural/Biological Products, 2017-2027, $ mn 57
Figure 32. Asia Pacific Biosurgery Market: Synthetic Products, 2017-2027, $ mn 58
Figure 33. Breakdown of Asia Pacific Biosurgery Market by Application, 2020-2027, % of Revenue 61
Figure 34. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%) 61
Figure 35. Asia Pacific Biosurgery Market: Orthopedic Surgery, 2017-2027, $ mn 62
Figure 36. Asia Pacific Biosurgery Market: General Surgery, 2017-2027, $ mn 63
Figure 37. Asia Pacific Biosurgery Market: Neurological Surgery, 2017-2027, $ mn 64
Figure 38. Asia Pacific Biosurgery Market: Cardiovascular Surgery, 2017-2027, $ mn 65
Figure 39. Asia Pacific Biosurgery Market: Gynecological Surgery, 2017-2027, $ mn 66
Figure 40. Asia Pacific Biosurgery Market: Other Applications, 2017-2027, $ mn 67
Figure 41. Breakdown of APAC Biosurgery Market by Country, 2020 and 2027, % of Revenue 69
Figure 42. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%) 70
Figure 43. Biosurgery Market in China, 2017-2027, $ mn 71
Figure 44. Biosurgery Market in Japan, 2017-2027, $ mn 74
Figure 45. Biosurgery Market in India, 2017-2027, $ mn 76
Figure 46. Biosurgery Market in Australia, 2017-2027, $ mn 78
Figure 47. Biosurgery Market in South Korea, 2017-2027, $ mn 80
Figure 48. Biosurgery Market in Rest of APAC, 2017-2027, $ mn 82
Figure 49. Growth Stage of Asia Pacific Biosurgery Industry over the Forecast Period 84

 

Reviews

There are yet no reviews for this product.